Modulation of Kaposi's sarcoma-associated herpesvirus interleukin-6 function by hypoxia-upregulated protein 1

Journal of Virology

Volumn 88, Issue 16, 2014, Pages 9429-9441

  Giffin, Louise ^a   Yan, Feng ^b   Major, M Ben ^b   Damania, Blossom ^a  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA UPREGULATED PROTEIN 1; INTERLEUKIN 6; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DIMERIZATION; HUMAN HERPESVIRUS 8; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN SECRETION; PROTEIN STABILITY; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CELL LINE; CHEMOKINE CCL2; HEK293 CELLS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INTERLEUKIN-6; JANUS KINASES; SARCOMA, KAPOSI; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; UP-REGULATION; VIRAL PROTEINS;

EID: 84904864062     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00511-14     Document Type: Article

References (55)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869. http://dx.doi.org/10.1126/science.7997879.
2. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332:1186-1191. http://dx.doi.org/10.1056/NEJM199505043321802.
3. Gessain A, Sudaka A, Briere J, Fouchard N, Nicola M, Rio B, Arborio M, Troussard X, Audouin J, Diebold J. 1996. Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in nonhuman immunodeficiency virus-infected patients? Blood 87:414-416.
4. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay M, Clauvel J, Raphael M, Degos L, Sigaux F. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280.
5. Beral V, Peterman TA, Berkelman RL, Jaffe HW. 1990. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335:123-128. http://dx.doi.org/10.1016/0140-6736(90)90001-L.
6. Renne R, Lagunoff M, Zhong W, Ganem D. 1996. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J. Virol. 70:8151-8154.
7. Moore PS, Boshoff C, Weiss RA, Chang Y. 1996. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739-1744. http://dx.doi.org/10.1126/science.274.5293.1739.
8. Neipel F, Albrecht JC, Ensser A, Huang YQ, Li JJ, Friedman-Kien AE, Fleckenstein B. 1997. Human herpesvirus 8 encodes a homolog of interleukin-6. J. Virol. 71:839-842.
9. Nicholas J, Ruvolo VR, Burns WH, Sandford G, Wan X, Ciufo D, Hendrickson SB, Guo H-G, Hayward GS, Reixz MS. 1997. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat. Med. 3:287-292. http://dx.doi.org/10.1038/nm0397-287.
10. Sun R, Lin S-F, Staskus K, Gradoville L, Grogan E, Haase A, Miller G. 1999. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol. 73:2232-2242.
11. Chandriani S, Ganem D. 2010. Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus. J. Virol. 84:5565-5573. http://dx.doi.org/10.1128/JVI.02723-09.
12. Chen D, Sandford G, Nicholas J. 2009. Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6. J. Virol. 83: 722-733. http://dx.doi.org/10.1128/JVI.01517-08.
13. Aoki Y, Yarchoan R, Wyvill K, Okamoto S-i, Little RF, Tosato G. 2001. Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders. Blood 97:2173-2176. http://dx.doi.org/10.1182/blood.V97.7.2173.
14. Aoki Y, Tosato G, Fonville TW, Pittaluga S. 2001. Serum viral interleukin-6 in AIDS-related multicentric Castleman disease. Blood 97:2526-2527. http://dx.doi.org/10.1182/blood.V97.8.2526.
15. Parravicini C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore P, Chang Y. 1997. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am. J. Pathol. 151:1517-1522.
16. Aoki Y, Jaffe E, Chang Y, Jones K, Teruya-Feldstein J, Moore P, Tosato G. 1999. Angiogenesis and hematopoiesis induced by Kaposi's sarcomaassociated herpesvirus-encoded interleukin-6. Blood 93:4034-4043.
17. Suthaus J, Stuhlmann-Laeisz C, Tompkins VS, Rosean TR, Klapper W, Tosato G, Janz S, Scheller J, Rose-John S. 2012. HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice. Blood 119:5173-5181. http://dx.doi.org/10.1182/blood-2011-09-377705.
18. Mori Y, Nishimoto N, Ohno M, Inagi R, Dhepakson P, Amou K, Yoshizaki K, Yamanishi K. 2000. Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion. J. Med. Virol. 61:332-335. http://dx.doi.org/10.1002/1096-9071(200 007)61:3332::AID-JMV83.0.CO;2-3.
19. Zhou F, Xue M, Qin D, Zhu X, Wang C, Zhu J, Hao T, Cheng L, Chen X, Bai Z, Feng N, Gao S-J, Lu C. 2013. HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3+ signaling pathway. PLoS One 8:e53145. http://dx.doi.org/10.1371/journal.pone.0053145.
20. Hideshima T, Chauhan D, Teoh G, Raje N, Treon SP, Tai Y-T, Shima Y, Anderson KC. 2000. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virusencoded viral interleukin 6. Clin. Cancer Res. 6:1180-1189.
21. Molden J, Chang Y, You Y, Moore PS, Goldsmith MA. 1997. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J. Biol. Chem. 272:19625-19631. http://dx.doi.org/10.1074/jbc.272.31.19625.
22. Osborne J, Moore PS, Chang Y. 1999. KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum. Immunol. 60:921-927. http://dx.doi.org/10.1016/S0198-8859(99)00083-X.
23. Aoki Y, Narazaki M, Kishimoto T, Tosato G. 2001. Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus. Blood 98:3042-3049. http://dx.doi.org/10.1182/blood.V98.10.3042.
24. Chow D-C, He X-L, Snow AL, Rose-John S, Garcia KC. 2001. Structure of an extracellular gp130 cytokine receptor signaling complex. Science 291:2150-2155. http://dx.doi.org/10.1126/science.1058308.
25. Wan X, Wang H, Nicholas J. 1999. Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6. J. Virol. 73:8268-8278.
26. Hu F, Nicholas J. 2006. Signal transduction by human herpesvirus 8 viral interleukin-6 (vIL-6) is modulated by the nonsignaling gp80 subunit of the IL-6 receptor complex and is distinct from signaling induced by human IL-6. J. Virol. 80:10874-10878. http://dx.doi.org/10.1128/JVI.00767-06.
27. Meads MB, Medveczky PG. 2004. Kaposi's sarcoma-associated herpesvirus-encoded viral interleukin-6 is secreted and modified differently than human interleukin-6: evidence for a unique autocrine signaling mechanism. J. Biol. Chem. 279:51793-51803. http://dx.doi.org/10.1074/jbc.M407382200.
28. Chen D, Choi YB, Sandford G, Nicholas J. 2009. Determinants of secretion and intracellular localization of human herpesvirus 8 interleukin-6. J. Virol. 83:6874-6882. http://dx.doi.org/10.1128/JVI.02625-08.
29. Chen D, Cousins E, Sandford G, Nicholas J. 2012. Human herpesvirus 8 viral interleukin-6 interacts with splice variant 2 of vitamin K epoxide reductase complex subunit 1. J. Virol. 86:1577-1588. http://dx.doi.org/10.1128/JVI.05782-11.
30. Cousins E, Nicholas J. 2013. Role of human herpesvirus 8 interleukin-6-activated gp130 signal transducer in primary effusion lymphoma cell growth and viability. J. Virol. 87:10816-10827. http://dx.doi.org/10.1128/JVI.02047-13.
31. Chen D, Gao Y, Nicholas J. 2014. Human herpesvirus 8 interleukin-6 contributes to primary effusion lymphoma cell viability via suppression of proapoptotic cathepsin D, a cointeraction partner of vitamin K epoxide reductase complex subunit 1 variant 2. J. Virol. 88:1025-1038. http://dx.doi.org/10.1128/JVI.02830-13.
32. Ozawa K, Tsukamoto Y, Hori O, Kitao Y, Yanagi H, Stern DM, Ogawa S. 2001. Regulation of tumor angiogenesis by oxygen-regulated protein 150, an inducible endoplasmic reticulum chaperone. Cancer Res. 61: 4206-4213.
33. Wang Y, Wu Z, Li D, Wang D, Wang X, Feng X, Xia M. 2011. Involvement of oxygen-regulated protein 150 in AMP-activated protein kinase-mediated alleviation of lipid-induced endoplasmic reticulum stress. J. Biol. Chem. 286:11119-11131. http://dx.doi.org/10.1074/jbc.M110.203323.
34. Stojadinovic A, Hooke JA, Shriver CD, Nissan A, Kovatich AJ, Kao TC, Ponniah S, Peoples GE, Moroni M. 2007. HYOU1/Orp150 expression in breast cancer. Med. Sci. Monit. 13:BR231-BR239.
35. Chiu C-C, Lin C-Y, Lee L-Y, Chen Y-J, Lu Y-C, Wang H-M, Liao C-T, Chang JT-C, Cheng A-J. 2011. Molecular chaperones as a common set of proteins that regulate the invasion phenotype of head and neck cancer. Clin. Cancer Res. 17:4629-4641. http://dx.doi.org/10.1158/1078-0432.CCR-10-2107.
36. Kuwabara K, Matsumoto M, Ikeda J, Hori O, Ogawa S, Maeda Y, Kitagawa K, Imuta N, Kinoshita T, Stern DM, Yanagi H, Kamada T. 1996. Purification and characterization of a novel stress protein, the 150-kDa oxygen-regulated protein (ORP150), from cultured rat astrocytes and its expression in ischemic mouse brain. J. Biol. Chem. 271:5025-5032. http://dx.doi.org/10.1074/jbc.271.9.5025.
37. Haque M, Davis DA, Wang V, Widmer I, Yarchoan R. 2003. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia. J. Virol. 77: 6761-6768. http://dx.doi.org/10.1128/JVI.77.12.6761-6768.2003.
38. Ozawa K, Kuwabara K, Tamatani M, Takatsuji K, Tsukamoto Y, Kaneda S, Yanagi H, Stern DM, Eguchi Y, Tsujimoto Y, Ogawa S, Tohyama M. 1999. 150-kDa oxygen-regulated protein (ORP150) suppresses hypoxia-induced apoptotic cell death. J. Biol. Chem. 274:6397-6404. http://dx.doi.org/10.1074/jbc.274.10.6397.
39. Ozawa K, Kondo T, Hori O, Kitao Y, Stern DM, Eisenmenger W, Ogawa S, Ohshima T. 2001. Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport. J. Clin. Invest. 108:41-50. http://dx.doi.org/10.1172/JCI11772.
40. Wolf MJ, Hoos A, Bauer J, Boettcher S, Knust M, Weber A, Simonavicius N, Schneider C, Lang M, Sturzl M, Croner RS, Konrad A, Manz MG, Moch H, Aguzzi A, van Loo G, Pasparakis M, Prinz M, Borsig L, Heikenwalder M. 2012. Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell 22:91-105. http://dx.doi.org/10.1016/j.ccr.2012.05.023.
41. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW. 2011. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475:222-225. http://dx.doi.org/10.1038/nature10138.
42. Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU. 2003. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J. Virol. 77:4205-4220. http://dx.doi.org/10.1128/JVI.77.7.4205-4220.2003.
43. Wang L, Wakisaka N, Tomlinson CC, DeWire SM, Krall S, Pagano JS, Damania B. 2004. The Kaposi's sarcoma-associated herpesvirus (KSHV/ HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res. 64:2774-2781. http://dx.doi.org/10.1158/0008-5472.CAN-03-3653.
44. West J, Damania B. 2008. Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J. Virol. 82: 5440-5449. http://dx.doi.org/10.1128/JVI.02590-07.
45. Rose-John S, Schooltink H, Schmitz-Van de Leur H, Mullberg J, Heinrich PC, Graeve L. 1993. Intracellular retention of interleukin-6 abrogates signaling. J. Biol. Chem. 268:22084-22091.
46. Isono T. 2011. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation. PLoS One 6:e18959. http://dx.doi.org/10.1371/journal.pone.0018959.
47. Bhatt AP, Bhende PM, Sin S-H, Roy D, Dittmer DP, Damania B. 2010. Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas. Blood 115: 4455-4463. http://dx.doi.org/10.1182/blood-2009-10-251082.
48. Siesser PF, Motolese M, Walker MP, Goldfarb D, Gewain K, Yan F, Kulikauskas RM, Chien AJ, Wordeman L, Major MB. 2012. FAM123A binds to microtubules and inhibits the guanine nucleotide exchange factor ARHGEF2 to decrease actomyosin contractility. Sci. Signal. 5:ra64. http://dx.doi.org/10.1126/scisignal.2002871.
49. Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, Clauvel J, Agbalika F. 2000. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood 96:2069-2073.
50. Matsuyama M, Suzuki T, Tsuboi H, Ito S, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T. 2007. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease. Intern. Med. 46:771-774. http://dx.doi.org/10.2169/internalmedicine.46.6262.
51. Dela Cruz CS, Lee Y, Viswanathan SR, El-Guindy AS, Gerlach J, Nikiforow S, Shedd D, Gradoville L, Miller G. 2004. N-linked glycosylation is required for optimal function of Kaposi's sarcoma herpesvirusencoded, but not cellular, interleukin 6. J. Exp. Med. 199:503-514. http://dx.doi.org/10.1084/jem.20031205.
52. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JOD, Weiss RA, O'Leary JJ. 1995. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat. Med. 1:1274-1278. http://dx.doi.org/10.1038/nm1295-1274.
53. Hussein M. 2008. Immunohistological evaluation of immune cell infiltrate in cutaneous Kaposi's sarcoma. Cell Biol. Int. 32:157-162. http://dx.doi.org/10.1016/j.cellbi.2007.08.021.
54. Morris VA, Punjabi AS, Wells RC, Wittkopp CJ, Vart R, Lagunoff M. 2012. The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation. Virology 428:112-120. http://dx.doi.org/10.1016/j.virol.2012.03.013.
55. Wu J, Xu Y, Mo D, Huang P, Sun R, Huang L, Pan S, Xu J. 2014. Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 promotes cell proliferation and migration by upregulating DNMT1 via STAT3 activation. PLoS One 9:e93478. http://dx.doi.org/10.1371/journal.pone.0093478.